ELAVL1 Role in Cell Fusion and Tunneling Membrane Nanotube Formations with Implication to Treat Glioma Heterogeneity

por Filippova, Natalia, Nabors, Louis B.
Publicado 2020

Growth Factor Dependent Regulation of Centrosome Function and Genomic Instability by HuR

por Filippova, Natalia, Yang, Xiuhua, Nabors, Louis Burt
Publicado 2015

Blocking PD1/PDL1 Interactions Together with MLN4924 Therapy is a Potential Strategy for Glioma Treatment

por Filippova, Natalia, Yang, Xiuhua, An, Zixiao, Nabors, Louis B, Pereboeva, Larisa
Publicado 2018

COVD-23. PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMIC

por Schaff, Lauren, Lobbous, Mina, Bozza, Alexis, Carlow, Dean, Nabors, Louis, Grommes, Christian
Publicado 2020

Undesired impact of iron supplement on MRI assessment of post-treatment glioblastoma

por Park, Dahye, Lobbous, Mina, Nabors, Louis B, Markert, James M, Kim, Jinsuh
Publicado 2022

Primary central nervous system angiosarcoma: two case reports

por Hackney, James R, Palmer, Cheryl Ann, Riley, Kristen O, Cure, Joel K, Fathallah-Shaykh, Hassan M, Nabors, Louis B
Publicado 2012

An Update on Neurofibromatosis Type 1-Associated Gliomas

por Lobbous, Mina, Bernstock, Joshua D., Coffee, Elizabeth, Friedman, Gregory K., Metrock, Laura K., Chagoya, Gustavo, Elsayed, Galal, Nakano, Ichiro, Hackney, James R., Korf, Bruce R., Nabors, Louis B.
Publicado 2020

TIPS-08 ACTION: A RANDOMIZED PHASE 3 STUDY OF DORDAVIPRONE (ONC201) IN PATIENTS WITH NEWLY DIAGNOSED H3 K27M-MUTANT DIFFUSE GLIOMA

por Arrillaga-Romany, Isabel, Lassman, Andrew, McGovern, Susan, Mueller, Sabine, Nabors, Louis Burt, van den Bent, Martin, Vogelbaum, Michael, Allen, Joshua E, Melemed, Allen S, Tarapore, Rohinton, Wen, Patrick, Cloughsey, Timothy
Publicado 2023

Diagnosing growth in low-grade gliomas with and without longitudinal volume measurements: A retrospective observational study

por Fathallah-Shaykh, Hassan M., DeAtkine, Andrew, Coffee, Elizabeth, Khayat, Elias, Bag, Asim K., Han, Xiaosi, Warren, Paula Province, Bredel, Markus, Fiveash, John, Markert, James, Bouaynaya, Nidhal, Nabors, Louis B.
Publicado 2019

An expanded safety/feasibility study of the EMulate Therapeutics Voyager™ System in patients with recurrent glioblastoma

por Barkhoudarian, Garni, Badruddoja, Michael, Blondin, Nicholas, Chowdhary, Sajeel, Cobbs, Charles, Duic, Julius Paul, Flores, John Paul, Fonkem, Ekokobe, McClay, Edward, Nabors, Louis Burt, Salacz, Michael, Taylor, Lynn, Vaillant, Brian, Gill, Jaya, Kesari, Santosh
Publicado 2023

Methylmercury exposure, genetic variation in metabolic enzymes, and the risk of glioma

por Creed, Jordan H., Peeri, Noah C., Anic, Gabriella M., Thompson, Reid C., Olson, Jeffrey J., LaRocca, Renato V., Chowdhary, Sajeel A., Brockman, John D., Gerke, Travis A., Nabors, Louis B., Egan, Kathleen M.
Publicado 2019

Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome

por Weller, Michael, Nabors, Louis Burt, Gorlia, Thierry, Leske, Henning, Rushing, Elisabeth, Bady, Pierre, Hicking, Christine, Perry, James, Hong, Yong-Kil, Roth, Patrick, Wick, Wolfgang, Goodman, Simon L., Hegi, Monika E., Picard, Martin, Moch, Holger, Straub, Josef, Stupp, Roger
Publicado 2016

Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: an open-label, multi-center phase I study

por Schaff, Lauren R., Lobbous, Mina, Carlow, Dean, Schofield, Ryan, Gavrilovic, Igor T., Miller, Alexandra M., Stone, Jacqueline B., Piotrowski, Anna F., Sener, Ugur, Skakodub, Anna, Acosta, Edward P., Ryan, Kevin J., Mellinghoff, Ingo K., DeAngelis, Lisa M., Nabors, Louis B., Grommes, Christian
Publicado 2022

Glioma-initiating cells at tumor edge gain signals from tumor core cells to promote their malignancy

por Bastola, Soniya, Pavlyukov, Marat S., Yamashita, Daisuke, Ghosh, Sadashib, Cho, Heejin, Kagaya, Noritaka, Zhang, Zhuo, Minata, Mutsuko, Lee, Yeri, Sadahiro, Hirokazu, Yamaguchi, Shinobu, Komarova, Svetlana, Yang, Eddy, Markert, James, Nabors, Louis B., Bhat, Krishna, Lee, James, Chen, Qin, Crossman, David K., Shin-Ya, Kazuo, Nam, Do-Hyun, Nakano, Ichiro
Publicado 2020

Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study

por van den Bent, Martin, Gan, Hui K., Lassman, Andrew B., Kumthekar, Priya, Merrell, Ryan, Butowski, Nicholas, Lwin, Zarnie, Mikkelsen, Tom, Nabors, Louis B., Papadopoulos, Kyriakos P., Penas-Prado, Marta, Simes, John, Wheeler, Helen, Walbert, Tobias, Scott, Andrew M., Gomez, Erica, Lee, Ho-Jin, Roberts-Rapp, Lisa, Xiong, Hao, Bain, Earle, Ansell, Peter J., Holen, Kyle D., Maag, David, Reardon, David A.
Publicado 2017

Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with EGFR-amplified, recurrent glioblastoma: results from an international phase I multicenter trial

por Lassman, Andrew B, van den Bent, Martin J, Gan, Hui K, Reardon, David A, Kumthekar, Priya, Butowski, Nicholas, Lwin, Zarnie, Mikkelsen, Tom, Nabors, Louis B, Papadopoulos, Kyriakos P, Penas-Prado, Marta, Simes, John, Wheeler, Helen, Walbert, Tobias, Scott, Andrew M, Gomez, Erica, Lee, Ho-Jin, Roberts-Rapp, Lisa, Xiong, Hao, Ansell, Peter J, Bain, Earle, Holen, Kyle D, Maag, David, Merrell, Ryan
Publicado 2019

Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trial

por Griguer, Corinne E, Oliva, Claudia R, Coffey, Christopher S, Cudkowicz, Merit E, Conwit, Robin A, Gudjonsdottir, Anna L, Ecklund, Dixie J, Fedler, Janel K, Neill-Hudson, Tina M, Nabors, Louis B, Benge, Melanie, Hackney, James R, Chase, Marianne, Leonard, Timothy P, Patel, Toral, Colman, Howard, de la Fuente, Macarena, Chaudhary, Rekha, Marder, Karen, Kreisl, Teri, Mohile, Nimish, Chheda, Milan G, McNeill, Katharine, Kumthekar, Priya, Dogan, Aclan, Drappatz, Jan, Puduvalli, Vinay, Kowalska, Agnes, Graber, Jerome, Gerstner, Elizabeth, Clark, Stephen, Salacz, Michael, Markert, James
Publicado 2021